Evidence map›Paper›PMID 39330021›Full record

ReviewCurrent oncology (Toronto, Ont.)2024

COVID-19 and Cancer Care: A Review and Practical Guide to Caring for Cancer Patients in the Era of COVID-19.

Simon Claveau, Farhan Mahmood, Baraa Amir, Jennifer Jing Wah Kwan, Cheryl White, Joe Vipond, Lisa Iannattone

Abstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simon ClaveauDepartment of Medicine, McGill University, Montreal, QC H3A 0G4, Canada.
Farhan MahmoodDepartment of Medicine, McGill University, Montreal, QC H3A 0G4, Canada.ORCID 0000-0001-6036-1682
Baraa AmirCollege of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
Jennifer Jing Wah KwanIndependent Researcher, Burlington, ON L7N 3V2, Canada.
Cheryl WhiteIndependent Researcher, Toronto, ON M6P 3X9, Canada.ORCID 0000-0002-9745-3625
Joe VipondDepartment of Emergency Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Lisa IannattoneDepartment of Medicine, McGill University, Montreal, QC H3A 0G4, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, a novel infectious disease caused by the emergence of the SARS-CoV-2 virus in 2020, has had a profound impact on healthcare, both at the individual and population level. The impact at the population level was felt most acutely during the emergency phase of the pandemic, with hospital capacity issues leading to widespread disruptions and delays in the delivery of healthcare services such as screening programs and elective surgeries. While hospitals are no longer being acutely overwhelmed by COVID-19 patients, the impact of the virus on vulnerable patient populations such as cancer patients continues to be of ongoing consequence. Cancer patients remain at high risk of hospitalization, ICU admission, and death due to COVID-19, even in the era of vaccination. Infection prevention and risk mitigation strategies such air quality control, masking, testing, vaccination, and treatment should therefore be integrated into the usual care and counseling of cancer patients moving forward to avoid preventable morbidity and mortality from this infection and ensure the safety of this vulnerable cohort as they navigate their cancer diagnosis and treatment in the era of COVID-19.

Indexed as

COVID-19NeoplasmsSARS-CoV-2HumansPandemicscancer careCOVID-19infection preventionSARS-CoV-2

Identifiers

PMID39330021
PMCPMC11431468

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.